Compare KKR & Co Inc (KKR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KKR & Co Inc vs Tempus AI — how do they compare? KKR & Co Inc trades at $111.14 (market cap $93.20B), while Tempus AI trades at $55.65 (market cap $9.93B). The key difference: KKR & Co Inc is far larger — about 9.4× Tempus AI's market cap, and KKR & Co Inc pays a 0.75% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| KKR | TEM | |
|---|---|---|
Market Cap | $93.20B | $9.93B |
Sector | Financials | Broad Market / Factor |
52-Week High | $149.34 | $103.25 |
52-Week Low | $83.88 | $41.55 |
Enterprise Value | $15.76B | $10.56B |
Dividend Yield | 0.75% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KKR trades at $102.81, down 0.52% on the day, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $1.63 per share, beating estimates, and maintains robust analyst support with a consensus price target of $127.22. Recent news highlights active deal-making, including the acquisition of Integer Holdings and the closing of a $19.2 billion infrastructure fund, signaling growth momentum.
The outlook for KKR is positive, driven by earnings beats, strategic acquisitions, and strong institutional sentiment. Key risks include execution of large deals, market volatility, and interest rate sensitivity. The stock presents an opportunity for growth-oriented investors, supported by a high buy rating consensus and expanding asset management operations.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KKR & Co Inc
KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
